Drug Profile
Research programme: methionine aminopeptidase-2 inhibitors - Astex Therapeutics
Latest Information Update: 26 Sep 2011
Price :
$50
*
At a glance
- Originator Astex Therapeutics
- Class Small molecules
- Mechanism of Action Methionine aminopeptidase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours